Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue
Drug safety advice
- Bisphosphonates: osteonecrosis of the jaw
- Vigabatrin for infantile spasms: risk of movement disorders and MRI abnormalities
- Colchicine: reminder on risk of serious and fatal toxicity in overdose
- Orciprenaline sulphate (Alupent): withdrawal due to unfavourable benefit-risk profile
Yellow Card Scheme update
- MHRA Swine Flu ADR Portal now extended to include reporting of suspected reactions to swine influenza vaccines
Hot topics
- Medical and non-medical prescribing: mixing medicines in clinical practice
- Statins: updated product information on adverse reactions in patient leaflets
Stop press
- Oseltamivir (Tamiflu): update to Patient Information Leaflet
Other information from the MHRA
- Patient Information Leaflet of the month: Zocor Heart-Pro
- Introduction of the Traditional Herbal Registration Certification Mark
Drug Safety Update: Volume 3 Issue 4, November 2009 
